Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int J Mol Sci ; 25(18)2024 Sep 23.
Artículo en Inglés | MEDLINE | ID: mdl-39337708

RESUMEN

This study investigated the effects of ascochlorin (ASC), a natural compound derived from the fungus Ascochyta viciae, on adipogenesis and obesity. We determined the effects of ASC on 3T3-L1 preadipocytes and whether it ameliorated to mitigate high-fat diet (HFD)-induced obesity in C57BL/6J mice. We found that ASC significantly inhibited the differentiation of preadipocytes by modulating the Wnt/ß-catenin signaling pathway, a key regulator of adipogenic processes. Treatment with ASC not only reduced the mRNA and protein expression of key adipogenic transcription factors such as C/EBPα and PPARγ, but also reduced lipid accumulation both in vitro and in vivo. In addition, treatment HFD-fed mice with ASC significantly reduced their weight gain and adiposity vs. control mice. These results suggest that ASC has considerable potential as a therapeutic agent for obesity, owing to its dual action of inhibiting adipocyte differentiation and reducing lipid accumulation. Thus, ASC represents a promising candidate as a natural anti-obesity agent.


Asunto(s)
Adipocitos , Adipogénesis , Dieta Alta en Grasa , Obesidad , Vía de Señalización Wnt , Animales , Masculino , Ratones , Células 3T3-L1 , Adipocitos/efectos de los fármacos , Adipocitos/metabolismo , Adipogénesis/efectos de los fármacos , Alquenos , Fármacos Antiobesidad/farmacología , beta Catenina/metabolismo , Diferenciación Celular/efectos de los fármacos , Dieta Alta en Grasa/efectos adversos , Metabolismo de los Lípidos/efectos de los fármacos , Ratones Endogámicos C57BL , Obesidad/tratamiento farmacológico , Obesidad/metabolismo , Obesidad/etiología , Fenoles/farmacología , PPAR gamma/metabolismo , PPAR gamma/genética , Vía de Señalización Wnt/efectos de los fármacos
2.
J Med Food ; 8(3): 311-8, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16176140

RESUMEN

Cassia tora fiber supplement consisting of 2 g of soluble fiber extracted from Cassia semen (C. tora L.), 200 mg of alpha-tocopherol, 500 mg of ascorbic acid, and 300 mg of maltodextrin was formulated in a pack, and given to 15 type II diabetic subjects (seven men and eight women 57.1 +/- 2.9 years old) with instructions to take two packs per day for 2 months. Placebo contained maltodextrin only with a little brown caramel color. Lifestyle factors and dietary intakes of the subjects were not altered during the 2-month period. Serum total cholesterol was moderately (P < .1) decreased in the C. tora group compared with the age- and gender-matched placebo group, as was the ratio of apolipoprotein B to apolipoprotein A1 (P < .1). Levels of serum triglycerides and low-density lipoprotein-cholesterol tended to decrease more in the C. tora-supplemented group than in the placebo group. Serum alpha-tocopherol was increased (P < .01) but lipid peroxides were not significantly lower in the C. tora group. Fasting blood glucose, hemoglobin A1c, blood urea nitrogen, creatinine, and activities of serum aspartate aminotransferase and alanine aminotransferase were not changed by the fiber supplement. We concluded that C. tora supplements can help improve serum lipid status in type II diabetic subjects without serious adverse effects.


Asunto(s)
Cassia , Diabetes Mellitus Tipo 2/sangre , Fibras de la Dieta/administración & dosificación , Lípidos/sangre , Apolipoproteína A-I/sangre , Apolipoproteínas B/sangre , Ácido Ascórbico/administración & dosificación , LDL-Colesterol/sangre , Dieta , Suplementos Dietéticos , Femenino , Humanos , Corea (Geográfico) , Estilo de Vida , Masculino , Persona de Mediana Edad , Placebos , Extractos Vegetales , Polisacáridos/administración & dosificación , Sustancias Reactivas al Ácido Tiobarbitúrico/análisis , Triglicéridos/sangre , alfa-Tocoferol/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA